BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zagon IS, Donahue RN, McLaughlin PJ. Opioid growth factor-opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancers. Am J Physiol Regul Integr Comp Physiol 2009;297:R1154-61. [PMID: 19675283 DOI: 10.1152/ajpregu.00414.2009] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Qu N, Wang R, Meng Y, Liu N, Zhai J, Shan F. Methionine enkephalin inhibited cervical carcinoma via apoptosis promotion and reduction of myeloid derived suppressor cell infiltrated in tumor. Int Immunopharmacol 2022;110:108933. [PMID: 35738090 DOI: 10.1016/j.intimp.2022.108933] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Lath A, Santal AR, Kaur N, Kumari P, Singh NP. Anti-cancer peptides: their current trends in the development of peptide-based therapy and anti-tumor drugs. Biotechnol Genet Eng Rev 2022;:1-40. [PMID: 35699384 DOI: 10.1080/02648725.2022.2082157] [Reference Citation Analysis]
3 Patrad E, Khalighfard S, Khori V, Alizadeh AM. The other side of the coin: Positive view on the role of opioids in cancer. Eur J Pharmacol 2022;923:174888. [PMID: 35367422 DOI: 10.1016/j.ejphar.2022.174888] [Reference Citation Analysis]
4 Babaie S, Taghvimi A, Charkhpour M, Zarebkohan A, Keyhanvar P, Hamishehkar H. Optimization of Influential Variables in the Development of Buprenorphine and Bupivacaine Loaded Invasome for Dermal Delivery. Adv Pharm Bull 2021;11:522-9. [PMID: 34513627 DOI: 10.34172/apb.2021.060] [Reference Citation Analysis]
5 Huang H, Liu B, Qu N, Zhang S, Bai X, Handley M, Shan F. Research progress of opioid growth factor in immune-related diseases and cancer diseases. Int Immunopharmacol 2021;99:107713. [PMID: 34426103 DOI: 10.1016/j.intimp.2021.107713] [Reference Citation Analysis]
6 Vanderboom PM, Mun DG, Madugundu AK, Mangalaparthi KK, Saraswat M, Garapati K, Chakraborty R, Ebihara H, Sun J, Pandey A. Proteomic Signature of Host Response to SARS-CoV-2 Infection in the Nasopharynx. Mol Cell Proteomics 2021;20:100134. [PMID: 34400346 DOI: 10.1016/j.mcpro.2021.100134] [Reference Citation Analysis]
7 Scheau C, Draghici C, Ilie MA, Lupu M, Solomon I, Tampa M, Georgescu SR, Caruntu A, Constantin C, Neagu M, Caruntu C. Neuroendocrine Factors in Melanoma Pathogenesis. Cancers (Basel) 2021;13:2277. [PMID: 34068618 DOI: 10.3390/cancers13092277] [Reference Citation Analysis]
8 Liubchenko K, Kordbacheh K, Khajehdehi N, Visnjevac T, Ma F, Khan JS, Storey M, Abd-Elsayed A, Visnjevac O. Naltrexone's Impact on Cancer Progression and Mortality: A Systematic Review of Studies in Humans, Animal Models, and Cell Cultures. Adv Ther 2021;38:904-24. [PMID: 33337537 DOI: 10.1007/s12325-020-01591-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
9 Xie M, Liu D, Yang Y. Anti-cancer peptides: classification, mechanism of action, reconstruction and modification. Open Biol 2020;10:200004. [PMID: 32692959 DOI: 10.1098/rsob.200004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
10 Li G, Li B, Song J, Wang N, Gao Z. Endomorphin-2 Analog Inhibits the Growth of DLD-1 and RKO Human Colon Cancer Cells by Inducing Cell Apoptosis. Med Sci Monit 2020;26:e921251. [PMID: 32336747 DOI: 10.12659/MSM.921251] [Reference Citation Analysis]
11 Wang R, Zhang Y, Shan F. Interaction of opioid growth factor (OGF) and opioid antagonist and their significance in cancer therapy. International Immunopharmacology 2019;75:105785. [DOI: 10.1016/j.intimp.2019.105785] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
12 Qu N, Wang X, Meng Y, Shan F. Prospective oncotarget for gynecological cancer: Opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis. Int Immunopharmacol 2019;75:105723. [PMID: 31408839 DOI: 10.1016/j.intimp.2019.105723] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Zheng T, Qiu J, Li C, Lin X, Tang X, Hua K. Long noncoding RNA LINC00673 promotes the proliferation and metastasis of epithelial ovarian cancer by associating with opioid growth factor receptor. Onco Targets Ther 2019;12:6145-56. [PMID: 31496722 DOI: 10.2147/OTT.S209784] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Zhu L, Titone R, Robertson DM. The impact of hyperglycemia on the corneal epithelium: Molecular mechanisms and insight. Ocul Surf 2019;17:644-54. [PMID: 31238114 DOI: 10.1016/j.jtos.2019.06.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
15 Wang X, Tian J, Jiao X, Geng J, Wang R, Liu N, Gao X, Griffin N, Gao Y, Shan F. The novel mechanism of anticancer effect on gastric cancer through inducing G0/G1 cell cycle arrest and caspase-dependent apoptosis in vitro and in vivo by methionine enkephalin. Cancer Manag Res 2018;10:4773-87. [PMID: 30425572 DOI: 10.2147/CMAR.S178343] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
16 Wu Y, Xiong Q, Li S, Yang X, Ge F. Integrated Proteomic and Transcriptomic Analysis Reveals Long Noncoding RNA HOX Transcript Antisense Intergenic RNA (HOTAIR) Promotes Hepatocellular Carcinoma Cell Proliferation by Regulating Opioid Growth Factor Receptor (OGFr). Mol Cell Proteomics 2018;17:146-59. [PMID: 29079719 DOI: 10.1074/mcp.RA117.000277] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
17 McLaughlin PJ, Cain JD, Titunick MB, Sassani JW, Zagon IS. Topical Naltrexone Is a Safe and Effective Alternative to Standard Treatment of Diabetic Wounds. Adv Wound Care (New Rochelle) 2017;6:279-88. [PMID: 28894635 DOI: 10.1089/wound.2016.0725] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
18 Wang DM, Jiao X, Plotnikoff NP, Griffin N, Qi RQ, Gao XH, Shan FP. Killing effect of methionine enkephalin on melanoma in vivo and in vitro. Oncol Rep 2017;38:2132-40. [PMID: 28849104 DOI: 10.3892/or.2017.5918] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
19 Ludwig MD, Zagon IS, McLaughlin PJ. Featured Article: Serum [Met5]-enkephalin levels are reduced in multiple sclerosis and restored by low-dose naltrexone. Exp Biol Med (Maywood) 2017;242:1524-33. [PMID: 28766982 DOI: 10.1177/1535370217724791] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
20 Kim JY, Ahn HJ, Kim JK, Kim J, Lee SH, Chae HB. Morphine Suppresses Lung Cancer Cell Proliferation Through the Interaction with Opioid Growth Factor Receptor: An In Vitro and Human Lung Tissue Study. Anesth Analg 2016;123:1429-36. [PMID: 27167686 DOI: 10.1213/ANE.0000000000001293] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
21 Stockdale DP, Titunick MB, Biegler JM, Reed JL, Hartung AM, Wiemer DF, McLaughlin PJ, Neighbors JD. Selective opioid growth factor receptor antagonists based on a stilbene isostere. Bioorg Med Chem 2017;25:4464-74. [PMID: 28693915 DOI: 10.1016/j.bmc.2017.06.035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
22 Wang DM, Wang GC, Yang J, Plotnikoff NP, Griffin N, Han YM, Qi RQ, Gao XH, Shan FP. Inhibition of the growth of human melanoma cells by methionine enkephalin. Mol Med Rep 2016;14:5521-7. [PMID: 27878237 DOI: 10.3892/mmr.2016.5941] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
23 Xu X, Gao Y, Wen L, Zhai Z, Zhang S, Shan F, Feng J. Methionine enkephalin regulates microglia polarization and function. International Immunopharmacology 2016;40:90-7. [DOI: 10.1016/j.intimp.2016.08.037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
24 Zhao D, Plotnikoff N, Griffin N, Song T, Shan F. Methionine enkephalin, its role in immunoregulation and cancer therapy. International Immunopharmacology 2016;37:59-64. [DOI: 10.1016/j.intimp.2016.02.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
25 Schulz CA, Christensson A, Ericson U, Almgren P, Hindy G, Nilsson PM, Struck J, Bergmann A, Melander O, Orho-Melander M. High Level of Fasting Plasma Proenkephalin-A Predicts Deterioration of Kidney Function and Incidence of CKD. J Am Soc Nephrol 2017;28:291-303. [PMID: 27401687 DOI: 10.1681/ASN.2015101177] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 3.2] [Reference Citation Analysis]
26 Kren NP, Zagon IS, McLaughlin PJ. Featured Article: Nuclear export of opioid growth factor receptor is CRM1 dependent. Exp Biol Med (Maywood) 2016;241:273-81. [PMID: 26429201 DOI: 10.1177/1535370215605585] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
27 Wang Q, Gao X, Yuan Z, Wang Z, Meng Y, Cao Y, Plotnikoff NP, Griffin N, Shan F. Methionine enkephalin (MENK) improves lymphocyte subpopulations in human peripheral blood of 50 cancer patients by inhibiting regulatory T cells (Tregs). Hum Vaccin Immunother 2014;10:1836-40. [PMID: 25424790 DOI: 10.4161/hv.28804] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
28 Mizerska-Dudka M, Kandefer-Szerszeń M. Opioids, Neutral Endopeptidase, its Inhibitors and Cancer: Is There a Relationship among them? Arch Immunol Ther Exp (Warsz) 2015;63:197-205. [PMID: 25193979 DOI: 10.1007/s00005-014-0311-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
29 Immonen JA, Zagon IS, Mclaughlin PJ. Featured Article: Selective blockade of the OGF–OGFr pathway by naltrexone accelerates fibroblast proliferation and wound healing. Exp Biol Med (Maywood) 2014;239:1300-9. [DOI: 10.1177/1535370214543061] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
30 Immonen JA, Zagon IS, McLaughlin PJ. Topical Naltrexone as Treatment for Type 2 Diabetic Cutaneous Wounds. Adv Wound Care (New Rochelle) 2014;3:419-27. [PMID: 24940556 DOI: 10.1089/wound.2014.0543] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
31 Zagon IS, McLaughlin PJ. Opioid growth factor and the treatment of human pancreatic cancer: A review. World J Gastroenterol 2014; 20(9): 2218-2223 [PMID: 24605021 DOI: 10.3748/wjg.v20.i9.2218] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
32 McLaughlin PJ, Zagon IS. Novel treatment for triple-negative breast and ovarian cancer: endogenous opioid suppression of women's cancers. Expert Rev Anticancer Ther 2014;14:247-50. [PMID: 24397732 DOI: 10.1586/14737140.2014.867234] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
33 Li W, Chen W, Herberman RB, Plotnikoff NP, Youkilis G, Griffin N, Wang E, Lu C, Shan F. Immunotherapy of cancer via mediation of cytotoxic T lymphocytes by methionine enkephalin (MENK). Cancer Lett 2014;344:212-22. [PMID: 24291668 DOI: 10.1016/j.canlet.2013.10.029] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
34 Zagon IS, Porterfield NK, McLaughlin PJ. Opioid growth factor - opioid growth factor receptor axis inhibits proliferation of triple negative breast cancer. Exp Biol Med (Maywood). 2013;238:589-599. [PMID: 23918871 DOI: 10.1177/1535370213489492] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
35 Rogosnitzky M, Finegold MJ, Mclaughlin PJ, Zagon IS. Opioid growth factor (OGF) for hepatoblastoma: a novel non-toxic treatment. Invest New Drugs 2013;31:1066-70. [DOI: 10.1007/s10637-012-9918-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
36 Hua H, Lu C, Li W, Meng J, Wang D, Plotnikoff NP, Wang E, Shan F. Comparison of stimulating effect on subpopulations of lymphocytes in human peripheral blood by methionine enkephalin with IL-2 and IFN-γ. Hum Vaccin Immunother 2012;8:1082-9. [PMID: 22854663 DOI: 10.4161/hv.20759] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
37 Cai Z, Ratka A. Opioid system and Alzheimer's disease. Neuromolecular Med 2012;14:91-111. [PMID: 22527793 DOI: 10.1007/s12017-012-8180-3] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
38 Chen W, Liu J, Meng J, Lu C, Li X, Wang E, Shan F. Macrophage polarization induced by neuropeptide methionine enkephalin (MENK) promotes tumoricidal responses. Cancer Immunol Immunother 2012;61:1755-68. [DOI: 10.1007/s00262-012-1240-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.6] [Reference Citation Analysis]
39 McLaughlin PJ, Keiper CL, Verderame MF, Zagon IS. Targeted overexpression of OGFr in epithelium of transgenic mice suppresses cell proliferation and impairs full-thickness wound closure. Am J Physiol Regul Integr Comp Physiol 2012;302:R1084-90. [PMID: 22338080 DOI: 10.1152/ajpregu.00670.2011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
40 Donahue RN, Mclaughlin PJ, Zagon IS. Under-expression of the opioid growth factor receptor promotes progression of human ovarian cancer. Exp Biol Med (Maywood) 2012;237:167-77. [DOI: 10.1258/ebm.2011.011321] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
41 Donahue RN, McLaughlin PJ, Zagon IS. Low-dose naltrexone targets the opioid growth factor-opioid growth factor receptor pathway to inhibit cell proliferation: mechanistic evidence from a tissue culture model. Exp Biol Med (Maywood) 2011;236:1036-50. [PMID: 21807817 DOI: 10.1258/ebm.2011.011121] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
42 Donahue RN, Mclaughlin PJ, Zagon IS. Low-dose naltrexone suppresses ovarian cancer and exhibits enhanced inhibition in combination with cisplatin. Exp Biol Med (Maywood) 2011;236:883-95. [DOI: 10.1258/ebm.2011.011096] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
43 Mclaughlin PJ, Stucki JK, Zagon IS. Modulation of the opioid growth factor ([Met5]-enkephalin)-opioid growth factor receptor axis: Novel therapies for squamous cell carcinoma of the head and neck. Head Neck 2012;34:513-9. [DOI: 10.1002/hed.21759] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
44 Shan F, Xia Y, Wang N, Meng J, Lu C, Meng Y, Plotnikoff NP. Functional modulation of the pathway between dendritic cells (DCs) and CD4+T cells by the neuropeptide: Methionine enkephalin (MENK). Peptides 2011;32:929-37. [DOI: 10.1016/j.peptides.2011.01.033] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 3.0] [Reference Citation Analysis]
45 Zagon IS, Donahue RN, Bonneau RH, Mclaughlin PJ. T lymphocyte proliferation is suppressed by the opioid growth factor ([Met5]-enkephalin)–opioid growth factor receptor axis: Implication for the treatment of autoimmune diseases. Immunobiology 2011;216:579-90. [DOI: 10.1016/j.imbio.2010.09.014] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 3.8] [Reference Citation Analysis]
46 Donahue RN, McLaughlin PJ, Zagon IS. The opioid growth factor (OGF) and low dose naltrexone (LDN) suppress human ovarian cancer progression in mice. Gynecol Oncol 2011;122:382-8. [PMID: 21531450 DOI: 10.1016/j.ygyno.2011.04.009] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
47 Zagon IS, Donahue RN, Bonneau RH, Mclaughlin PJ. B lymphocyte proliferation is suppressed by the opioid growth factor–opioid growth factor receptor axis: Implication for the treatment of autoimmune diseases. Immunobiology 2011;216:173-83. [DOI: 10.1016/j.imbio.2010.06.001] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
48 Sayagués JM, Fontanillo C, Abad Mdel M, González-González M, Sarasquete ME, Chillon Mdel C, Garcia E, Bengoechea O, Fonseca E, Gonzalez-Diaz M, De las Rivas J, Muñoz-Bellvis L, Orfao A. Mapping of genetic abnormalities of primary tumours from metastatic CRC by high-resolution SNP arrays. PLoS One 2010;5:e13752. [PMID: 21060790 DOI: 10.1371/journal.pone.0013752] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
49 Bodnar RJ. Endogenous opiates and behavior: 2009. Peptides 2010;31:2325-59. [PMID: 20875476 DOI: 10.1016/j.peptides.2010.09.016] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
50 Cheng F, McLaughlin PJ, Banks WA, Zagon IS. Internalization of the opioid growth factor, [Met5]-enkephalin, is dependent on clathrin-mediated endocytosis for downregulation of cell proliferation. Am J Physiol Regul Integr Comp Physiol 2010;299:R774-85. [PMID: 20592180 DOI: 10.1152/ajpregu.00318.2010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
51 McLaughlin PJ, Zagon IS, Park SS, Conway A, Donahue RN, Goldenberg D. Growth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis. BMC Cancer 2009;9:369. [PMID: 19835629 DOI: 10.1186/1471-2407-9-369] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]